All three types of autosomal recessive spinal muscular atrophy map to
chromosome 5q11.2-q13.3 and are associated with deletions or mutations
of the SMN (survival motor neurone) gene. The availability of a test
to distinguish between the SMN gene and its nearly identical centromer
ic copy (C)BCD541 allows molecular diagnosis. We have analysed patient
s from 24 Belgian and 34 Turkish families for the presence or absence
of a deletion in the SMN gene. A homozygous deletion in the SMN gene w
as seen in 90% of unrelated SMA patients. A non-radioactive SSCP assay
allows for a semiquantitative analysis of the copy number of the cent
romeric and SMN genes. Hence, direct carrier detection has become feas
ible under certain conditions. We observed a phenotypically normal mal
e, father of an SMA type I patient, presenting with only a single copy
of the SMN gene and lacking both copies of the (C)BCD541 gene. This i
llustrates that a reduction of the total number of SMN and (C)BCD541 g
enes to a single SMN copy is compatible with normal life. In another S
MA type I family, there is evidence for a de novo deletion of the cent
romeric gene in a normal sib. This observation illustrates the suscept
ibility of the SMA locus to de novo deletions and rearrangements.